Logo image of BALY

BALLY'S CORP (BALY) Stock Fundamental Analysis

NYSE:BALY - New York Stock Exchange, Inc. - US05875B3042 - Common Stock - Currency: USD

9.27  +0.03 (+0.32%)

Fundamental Rating

2

Overall BALY gets a fundamental rating of 2 out of 10. We evaluated BALY against 131 industry peers in the Hotels, Restaurants & Leisure industry. BALY may be in some trouble as it scores bad on both profitability and health. BALY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BALY had negative earnings in the past year.
In the past year BALY had a positive cash flow from operations.
BALY had negative earnings in each of the past 5 years.
BALY had a positive operating cash flow in each of the past 5 years.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -5.48%, BALY is not doing good in the industry: 77.86% of the companies in the same industry are doing better.
BALY's Return On Equity of -51.52% is on the low side compared to the rest of the industry. BALY is outperformed by 64.89% of its industry peers.
BALY has a worse Return On Invested Capital (0.61%) than 77.10% of its industry peers.
Industry RankSector Rank
ROA -5.48%
ROE -51.52%
ROIC 0.61%
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

The Operating Margin of BALY (2.15%) is worse than 74.81% of its industry peers.
BALY has a Gross Margin of 54.32%. This is in the better half of the industry: BALY outperforms 64.89% of its industry peers.
In the last couple of years the Gross Margin of BALY has declined.
Industry RankSector Rank
OM 2.15%
PM (TTM) N/A
GM 54.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BALY is destroying value.
BALY has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BALY has more shares outstanding
BALY has a worse debt/assets ratio than last year.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BALY has an Altman-Z score of 0.36. This is a bad value and indicates that BALY is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.36, BALY is not doing good in the industry: 82.44% of the companies in the same industry are doing better.
A Debt/Equity ratio of 4.31 is on the high side and indicates that BALY has dependencies on debt financing.
BALY has a Debt to Equity ratio (4.31) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACC0.08
WACC8.11%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.75 indicates that BALY may have some problems paying its short term obligations.
BALY has a Current ratio of 0.75. This is comparable to the rest of the industry: BALY outperforms 40.46% of its industry peers.
A Quick Ratio of 0.72 indicates that BALY may have some problems paying its short term obligations.
BALY has a Quick ratio (0.72) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.72
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for BALY have decreased strongly by -13.94% in the last year.
The Revenue has decreased by -1.93% in the past year.
BALY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.16% yearly.
EPS 1Y (TTM)-13.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.7%
Revenue 1Y (TTM)-1.93%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%-4.74%

3.2 Future

BALY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.79% yearly.
The Revenue is expected to grow by 6.25% on average over the next years.
EPS Next Y85.86%
EPS Next 2Y37.91%
EPS Next 3Y23.79%
EPS Next 5YN/A
Revenue Next Year3.35%
Revenue Next 2Y4.87%
Revenue Next 3Y6.25%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALY. In the last year negative earnings were reported.
Also next year BALY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BALY is valued a bit cheaper than the industry average as 63.36% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.81
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40

4.3 Compensation for Growth

BALY's earnings are expected to grow with 23.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.91%
EPS Next 3Y23.79%

More info and screens

0

5. Dividend

5.1 Amount

BALY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BALLY'S CORP

NYSE:BALY (8/5/2025, 12:53:28 PM)

9.27

+0.03 (+0.32%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners79.52%
Inst Owner Change-0.69%
Ins Owners2.47%
Ins Owner Change-7.19%
Market Cap454.32M
Analysts50.91
Price Target13.92 (50.16%)
Short Float %0.79%
Short Ratio2.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-84.59%
Min EPS beat(2)-187.58%
Max EPS beat(2)18.41%
EPS beat(4)2
Avg EPS beat(4)-729.87%
Min EPS beat(4)-2765.33%
Max EPS beat(4)18.41%
EPS beat(8)2
Avg EPS beat(8)-615.91%
EPS beat(12)3
Avg EPS beat(12)-718.81%
EPS beat(16)4
Avg EPS beat(16)-567.8%
Revenue beat(2)0
Avg Revenue beat(2)-3.84%
Min Revenue beat(2)-4.31%
Max Revenue beat(2)-3.37%
Revenue beat(4)0
Avg Revenue beat(4)-4.56%
Min Revenue beat(4)-5.87%
Max Revenue beat(4)-3.37%
Revenue beat(8)0
Avg Revenue beat(8)-3.74%
Revenue beat(12)0
Avg Revenue beat(12)-3.75%
Revenue beat(16)1
Avg Revenue beat(16)-3.7%
PT rev (1m)-5.54%
PT rev (3m)-18.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)21.98%
EPS NY rev (1m)0%
EPS NY rev (3m)7.76%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF 5.43
P/B 0.57
P/tB N/A
EV/EBITDA 10.81
EPS(TTM)-8.58
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)1.71
OCFY18.42%
SpS49.4
BVpS16.25
TBVpS-56.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.48%
ROE -51.52%
ROCE 0.77%
ROIC 0.61%
ROICexc 0.63%
ROICexgc 1.39%
OM 2.15%
PM (TTM) N/A
GM 54.32%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Debt/EBITDA 10.04
Cap/Depr 91.53%
Cap/Sales 10.95%
Interest Coverage 0.18
Cash Conversion 24.49%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.72
Altman-Z 0.36
F-Score6
WACC8.11%
ROIC/WACC0.08
Cap/Depr(3y)125.58%
Cap/Depr(5y)105.92%
Cap/Sales(3y)17.68%
Cap/Sales(5y)13.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.7%
EPS Next Y85.86%
EPS Next 2Y37.91%
EPS Next 3Y23.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.93%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%-4.74%
Revenue Next Year3.35%
Revenue Next 2Y4.87%
Revenue Next 3Y6.25%
Revenue Next 5YN/A
EBIT growth 1Y147.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year413.88%
EBIT Next 3Y75.17%
EBIT Next 5YN/A
FCF growth 1Y28.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.09%
OCF growth 3Y11.25%
OCF growth 5Y3.91%